Biblio

Daou D., Sabbah R., Coaguila C., Boulahdour H..  2016.  CZT SPECT Cardiac Radionuclide Angiography: Feasibility of Data-Driven Respiratory-Motion Gating with REGAT Software. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 43:S154-S155.

Daou D., Sabbah R., Coaguila C., Boulahdour H..  2016.  CZT SPECT Cardiac Radionuclide Angiography: Feasibility of Data-Driven Respiratory-Motion Gating with REGAT Software. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 43:S154-S155.

Vorotyntsev MA, Antipov AE, Konev DV.  2017.  d Bromate anion reduction: novel autocatalytic (EC'') mechanism of electrochemical processes. Its implication for redox flow batteries of high energy and power densities. PURE AND APPLIED CHEMISTRY. 89:1429-1448.

Gonzalez-Lezana T, Scribano Y, Honvault P.  2014.  The D+ + H-2 Reaction: Differential and Integral Cross Sections at Low Energy and Rate Constants at Low Temperature. JOURNAL OF PHYSICAL CHEMISTRY A. 118:6416-6424.

Riethmuller D..  2015.  D. Riethmuller in reply to the article by G. Bleu et al.: Assessment of vacuum-assisted delivery in a Frank breech presentation. Gynecol Obstet Fertil 2015;43:123-7. GYNECOLOGIE OBSTETRIQUE & FERTILITE. 43:688-689.

Bezverkhyy I, Pujol Q, Dirand C, Herbst F, Macaud M, Behat J-P.  2020.  D-2 and H-2 adsorption capacity and selectivity in CHA zeolites: Effect of Si/Al ratio, cationic composition and temperature. MICROPOROUS AND MESOPOROUS MATERIALS. 302:110217.

Giraudet M, Bezverkhyy I, Weber G, Dirand C, Macaud M, Bellat J-P.  2018.  D-2/H-2 adsorption selectivity on FAU zeolites at 77.4 K: Influence of Si/Al ratio and cationic composition. MICROPOROUS AND MESOPOROUS MATERIALS. 270:211-219.

Chammas J, Sauer A, Pizzuto J, Pouthier F, Gaucher D, Marescaux J, Mutter D, Bourcier T.  2017.  Da Vinci Xi Robot-Assisted Penetrating Keratoplasty. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY. 6:21.

Allayous C., Guillot B., S. Rat D, Mortier L., Dutriaux C., Leccia M-T., Lacour J-P., Dalle S., Saiag P., Beylot-Barry M. et al..  2017.  Dabrafenib and Trametinib combination in real life patients including brain metastases: French experience within MelBase. ANNALS OF ONCOLOGY. 28

Allayous C., Guillot B., S. Rat D, Mortier L., Dutriaux C., Leccia M-T., Lacour J-P., Dalle S., Saiag P., Beylot-Barry M. et al..  2017.  Dabrafenib and Trametinib combination in real life patients including brain metastases: French experience within MelBase. ANNALS OF ONCOLOGY. 28

Dautriche A., Minello A., Cosme H., Jeudy G., Leleu C., Aubriot-Lorton M.H, Grandvuillemin A..  2015.  Daclatasvir and sofosbuvir-induced cutaneous adverse reaction with leukocytoclastic vasculitis lesions: first case report. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 29:54.

Hezode C, Lebray P, de Ledinghen V, Zoulim F, Di Martino V, Boyer N, Larrey D, Botta-Fridlund D, Silvain C, Fontaine H et al..  2017.  Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme. LIVER INTERNATIONAL. 37:1314-1324.

Hezode C, de Ledinghen V, Fontaine H, Zoulim F, Lebray P, Boyer N, Larrey DG, Silvain C, Botta-Fridlund D, Leroy V et al..  2015.  Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program. HEPATOLOGY. 62:314A.

Hezode C., De Ledinghen V., Fontaine H., Zoulim F., Lebray P., Boyer N., Dominique L., Silvain C., Botta-Fridlund D., Leroy V. et al..  2015.  Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: interim analysis of a French multicenter compassionate use program. JOURNAL OF VIRAL HEPATITIS. 22:29.

Hezode C., De Ledinghen V., Fontaine H., Zoulim F., Lebray P., Boyer N., Larrey D., Silvain C., Botta-Fridlund D., Leroy V. et al..  2015.  DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 3 INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM. JOURNAL OF HEPATOLOGY. 62:S265-S266.

Leroy V., Hezode C., Metivier S., Tateo M., Conti F., Nguyen-Khac E., Lacoste D., Vergniol J., Truchi R., Guyader D. et al..  2016.  DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV INFECTION AND DECOMPENSATED CIRRHOSIS: INTERIM ANALYSIS OF A FRENCH MULTICENTRE COMPASSIONATE USE PROGRAMME. JOURNAL OF HEPATOLOGY. 64:S829.

Hezode C., De Ledinghen V., Fontaine H., Zoulim F., Lebray P., Boyer N., Dominique L., Silvain C., Botta-Fridlund D., Leroy V. et al..  2015.  Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: interim analysis of a French multicenter compassionate use program. JOURNAL OF VIRAL HEPATITIS. 22:29.

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.  2018.  Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort. ARTHRITIS & RHEUMATOLOGY. 70

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.  2019.  DACTYLITIS IN EARLY SPONDYLOARTHRITIS. DATA FROM THE DESIR COHORT. ANNALS OF THE RHEUMATIC DISEASES. 78:1258-1259.

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.  2020.  Dactylitis in early spondyloarthritis. Data from the prospective French national cohort DESIR. JOINT BONE SPINE. 87:497-499.

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.  2019.  Dactylitis Occurrence in Early Spondyloarthritis: Five Years Data from a French National Prospective Cohort. ARTHRITIS & RHEUMATOLOGY. 71

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.  2019.  Dactylitis Occurrence in Early Spondyloarthritis: Five Years Data from a French National Prospective Cohort. ARTHRITIS & RHEUMATOLOGY. 71

Poirrier P.  2015.  Daft Punk, the Web and the disco: Cultural revival in the digital age. FRENCH CULTURAL STUDIES. 26:368-381.

Strenna L, Chahraoui K, Reveillere C.  2014.  The daily hassles of first year students of the French ``grandes ecoles'': Relationships with perceived mental health and quality of life. ANNALES MEDICO-PSYCHOLOGIQUES. 172:369-375.

Filippo A, Renaud deCrevoisier, Stefanie C, Gilles C, Berardino DBari.  2018.  Daily IGRT for prostate cancer: Can we stop the train? RADIOTHERAPY AND ONCOLOGY. 128:389-390.